COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹53 Cr | ₹58 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr |
What is the latest Contingent Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹53 Cr |
| Mar2025 | ₹58 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹6.07 Cr |
| Mar2022 | ₹6.07 Cr |
How is Contingent Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹53 Cr | -7.96 | |
| Mar2025 | ₹58 Cr | 219.82 | |
| Mar2024 | ₹18 Cr | 198.50 | |
| Mar2023 | ₹6.07 Cr | 0.00 | |
| Mar2022 | ₹6.07 Cr | - | |
Compare Contingent Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,949.2 Cr | -3.7% | -4.6% | -49.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -3.7% |
-4.6% |
-49.9% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses